United States · FDA National Drug Code directory
Glycopyrrolate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76045-208_d8f5e3e4-34e3-4e52-b76d-69e210e649d5
- Product NDC
- 76045-208
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Glycopyrrolate
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201030
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYCOPYRROLATE — .2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BLISTER PACK in 1 CARTON (76045-208-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-208-02) / 2 mL in 1 SYRINGE, GLASS · 76045-208-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →